Protocol Ledger

NCT05838885 · Phase II · COMPLETED

A Trial of YPEG-rhGH in Children With Short Stature

Interventional Phase II clinical trial protocol NCT05838885 sponsored by Xiamen Amoytop Biotech Co in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-02-15 Enrollment: 78 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05838885
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)78 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05838885
Protocol FieldVerified Registry Value
NCT IdentifierNCT05838885
Consolidated Lead SponsorXiamen Amoytop Biotech Co
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment78 participants (ACTUAL)
Registered Start Date2022-02-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI